Choice of new treatment for patients with atopic dermatitis is associated with insurance status rather than race: A cross sectional study from commercial and Medicaid insurance claims databases
Authors
Maria C. Schneeweiss, Dermato-Pharmacoepidemiology Work Group, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States. Electronic address: mschneeweiss@bwh.harvard.edu.
Robert J. Glynn, Dermato-Pharmacoepidemiology Work Group, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States; Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States.
Priyanka Anand, Dermato-Pharmacoepidemiology Work Group, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States.
Yinzhu Jin, Dermato-Pharmacoepidemiology Work Group, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States.
Joan Landon, Dermato-Pharmacoepidemiology Work Group, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States.
Jonathan I. Silverberg, Department of Dermatology, George Washington University, Washington, DC, United States.
Document Type
Journal Article
Publication Date
10-6-2025
Journal
Journal of the American Academy of Dermatology
DOI
10.1016/j.jaad.2025.10.020
Keywords
Atopic dermatitis; Commercial insurance; Medicaid; biologics; insurance; race; socioeconomic; systemic treatment; topical treatment
APA Citation
Schneeweiss, Maria C.; Glynn, Robert J.; Anand, Priyanka; Jin, Yinzhu; Landon, Joan; and Silverberg, Jonathan I., "Choice of new treatment for patients with atopic dermatitis is associated with insurance status rather than race: A cross sectional study from commercial and Medicaid insurance claims databases" (2025). GW Authored Works. Paper 8308.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/8308
